Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model

Diabetes Care

Volumn 31, Issue 1, 2008, Pages 114-120

  Brandner, Johanna M ^a   Zacheja, Steffi ^b   Houdek, Pia ^a   Moll, Ingrid ^a   Lobmann, Ralf ^b,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26; CONNEXIN 34; CYTOKINE; GAP JUNCTION PROTEIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PRIMER DNA; RNA;

ADULT; AGED; ARTICLE; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; KERATINOCYTE; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; WOUND HEALING; BIOPSY; CULTURE TECHNIQUE; CYTOLOGY; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REFERENCE VALUE;

ADULT; AGED; BIOPSY; CELL CULTURE TECHNIQUES; CONNEXINS; CYTOKINES; DIABETES MELLITUS; DNA PRIMERS; FEMALE; HUMANS; KERATINOCYTES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA;

EID: 38149100384     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1304     Document Type: Article

References (26)

1. Lobmann R, Müller E, Kersken J, Bergmann K, Brunk-Loch S, Groene C, Lindloh C, Mertes B, Spraul M: The diabetic foot in Germany: analysis of quality in specialised diabetic wound care centers. TDFJ 10:68-72, 2007
2. Mast BA, Schultz GS: Interactions of cytokines, growth factors and proteases in acute and chronic wound. Wound Repair Regen 4:411-420, 1996
3. Lobmann R, Ambrosch A, Schultz GS, Waldmann K, Schiweck S, Lehnert H: Expression of matrixmetalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45:1011-1016, 2002
4. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW: Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104:236-240, 1995
5. Marionnet AV, Chardonnet Y, Viac J, Schmitt D: Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures. Exp Dermatol 6:22-28, 1997
6. Ito A, Sato T, Iga T, Mori Y: Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett 269:93-95, 1990
7. Lobmann R, Schultz G, Lehnert H: Molecular basis of wound healing in the diabetic foot syndrome. Diabetes Care 28:461-471, 2005
8. Coutinho P, Qiu C, Frank S, Tamber K, Becker D: Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int 27:525-541, 2003
9. Goliger JA, Paul DL: Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication. Mol Biol Cell 6:1491-1501, 1995
10. Brandner JM, Houdek P, Husing B, Kaiser C, Moll I: Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing. J Invest Dermatol 122:1310-1320, 2004
11. Kretz M, Euwens C, Hombach S, Eckardt D, Teubner B, Traub O, Willecke K, Ott T: Altered connexin expression and wound healing in the epidermis of connexin-deficient mice. J Cell Sci 116:3343-3452, 2003
12. Qiu C, Coutinho P, Frank S, Franke S, Law L-Y, Martin P, Green CR, Becker DL: Targeting connexin 43 expression accelerates the rate of wound repair. Curr Biol 13:1697-1703, 2003
13. Mori R, Power KT, Wang CM, Martin P, Becker DL: Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 119:5193-5203, 2006
14. Moustafa M, Simpson C, Glover M, Dawson RA, Tesfaye S, Creagh FM, Haddow D, Short R, Heller S, MacNeil S: A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers. Diabet Med 21:786-789, 2004
15. Brem H, Young J, Tomic-Canic M, Isaacs C, Ehrlich HP: Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int 11:23-31, 2003
16. Limat A, French LE, Blal L, Saurat JH, Hunziker T, Salomon D: Organotypic cultures of autologous hair follicle keratinocytes for the treatment of recurrent leg ulcers. J Am Acad Dermatol 48:207-214, 2003
17. Myers S, Navsaria H, Sanders R, Green C, Leigh I: Transplantation of keratinocytes in the treatment of wounds. Am J Surg 170:75-83, 1995
18. Acikgoz G, Devrim I, Ozdamar S: Comparison of keratinocyte proliferation in diabetic and non-diabetic inflamed gingiva. J Periodontol 75:989-994, 2004
19. Blakytny R, Jude EB, Martin Gibson J, Boulton AJ, Ferguson MW: Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 190:589-594, 2000
20. Terenghi G, Mann D, Kopelman PG, Anand P: trkA and trkC expression is increased in human diabetic skin. Neurosci Lett 228:33-36, 1997
21. Brandner JM, Houdek P, Quitschau T, Siemann-Harms U, Ohnemus U, Willhardt I, Moll I: An ex-vivo model to evaluate dressings & drugs for wound healing. example: influence of lucilia sericata extracts on wound healing progress. EWMA J 6:11-15, 2006
22. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G: Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7:442-452, 1999
23. Armstrong DG, Jude EB: The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 92:12-18, 2002
24. Saarialho-Kee UK: Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 290 (Suppl.):S47-S54, 1998
25. Wall SJ, Sampson MJ, Levell N, Murphy G: Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. Br J Dermatol 149:13-16, 2003
26. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC: Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 8:13-25, 2000